BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Medtronic
McKinsey
Dow
Merck
Queensland Health
Fuji
Novartis
Julphar
Covington

Generated: January 18, 2018

DrugPatentWatch Database Preview

Leflunomide - Generic Drug Details

« Back to Dashboard

Pharmacology for leflunomide

US Patents and Regulatory Information for leflunomide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz LEFLUNOMIDE leflunomide TABLET;ORAL 077087-001 Sep 13, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz LEFLUNOMIDE leflunomide TABLET;ORAL 077085-002 Sep 13, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ARAVA leflunomide TABLET;ORAL 020905-003 Sep 10, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms LEFLUNOMIDE leflunomide TABLET;ORAL 077084-002 Sep 13, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alembic Pharms Ltd LEFLUNOMIDE leflunomide TABLET;ORAL 091369-001 Nov 21, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ARAVA leflunomide TABLET;ORAL 020905-001 Sep 10, 1998 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz LEFLUNOMIDE leflunomide TABLET;ORAL 077087-002 Sep 13, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr LEFLUNOMIDE leflunomide TABLET;ORAL 077083-001 Sep 13, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr LEFLUNOMIDE leflunomide TABLET;ORAL 077083-002 Sep 13, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Heritage Pharms Inc LEFLUNOMIDE leflunomide TABLET;ORAL 077086-002 Sep 13, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for leflunomide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us ARAVA leflunomide TABLET;ORAL 020905-002 Sep 10, 1998 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ARAVA leflunomide TABLET;ORAL 020905-001 Sep 10, 1998 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ARAVA leflunomide TABLET;ORAL 020905-003 Sep 10, 1998 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ARAVA leflunomide TABLET;ORAL 020905-001 Sep 10, 1998 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ARAVA leflunomide TABLET;ORAL 020905-002 Sep 10, 1998 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ARAVA leflunomide TABLET;ORAL 020905-002 Sep 10, 1998 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ARAVA leflunomide TABLET;ORAL 020905-001 Sep 10, 1998 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ARAVA leflunomide TABLET;ORAL 020905-003 Sep 10, 1998 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ARAVA leflunomide TABLET;ORAL 020905-003 Sep 10, 1998 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Cipla
Chinese Patent Office
McKesson
Daiichi Sankyo
Farmers Insurance
Accenture
Medtronic
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot